Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

8716	Companies
152781	Keywords
88368	Articles
82102	Press releases

Home
Companies
Moderna, Inc.

BRIEF

published on 06/13/2025 at 01:30, 3 days 14 hours ago

Le vaccin contre le VRS de Moderna, mRESVIA, obtient l'approbation de la FDA pour les jeunes adultes à risque

Approbation De La FDA Maladies Chroniques Moderne Vaccin Contre Le VRS MRESVIA
BRIEF

published on 06/13/2025 at 01:30, 3 days 14 hours ago

Moderna's RSV Vaccine, mRESVIA, Gains FDA Approval for Younger At-Risk Adults

FDA Approval Chronic Conditions Moderna RSV Vaccine MRESVIA
PRESS RELEASE

published on 06/13/2025 at 01:25, 3 days 14 hours ago

Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
Moderna receives FDA approval to expand indication of mRESVIA vaccine for adults aged 18-59 at increased risk of RSV, based on Phase 3 study results showing safety and efficacy

FDA Approval Moderna RSV Vaccine Phase 3 Study MRESVIA
BRIEF

published on 06/11/2025 at 13:05, 5 days 3 hours ago

Moderna participera à la série d'appels scientifiques de Barclays

Presentation Barclays Moderne Événement Pour Les Investisseurs Technologie De L'ARNm
BRIEF

published on 06/11/2025 at 13:05, 5 days 3 hours ago

Moderna to Present at Barclays Science Call Series

MRNA Technology Presentation Moderna Barclays Investor Event
PRESS RELEASE

published on 06/11/2025 at 13:00, 5 days 3 hours ago

Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025
Moderna, Inc. announces participation in Barclays Speaking the Science Call Series on June 16th at 10:00am ET. Webcast available on Moderna's website

Webcast MRNA Medicine Moderna Barclays Investor Event
BRIEF

published on 05/31/2025 at 06:21, 16 days 9 hours ago

Moderna's mNEXSPIKE COVID-19 Vaccine Secures FDA Approval

FDA Approval COVID-19 Vaccine Clinical Trial Moderna MNEXSPIKE
BRIEF

published on 05/31/2025 at 06:21, 16 days 9 hours ago

Le vaccin mNEXSPIKE de Moderna contre la COVID-19 obtient l'approbation de la FDA

Essai Clinique Approbation De La FDA Moderne Vaccin Contre Le Covid-19 MNEXSPIKE
PRESS RELEASE

published on 05/31/2025 at 06:16, 16 days 9 hours ago

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Moderna's mNEXSPIKE, a new COVID-19 vaccine, receives FDA approval for high-risk age groups. The vaccine shows higher efficacy compared to the original mRNA-1273. Safety profile similar to Spikevax

FDA Approval COVID-19 Vaccine Moderna Efficacy MNEXSPIKE
BRIEF

published on 05/29/2025 at 00:05, 18 days 16 hours ago

Moderna Reports Progress and Setback in Avian Flu Vaccine Program

Moderna Vaccine Development Phase 1/2 Study H5 Avian Flu MRNA-1018

Accesswire

Published on 06/16/2025 at 15:00, 1 hour 5 minutes ago

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August
Published on 06/16/2025 at 15:00, 1 hour 5 minutes ago

Aeonian Resources Reports Highly Anomalous Copper Assay Results from Surface Sampling Program at Koocanusa Project, Southeast British Columbia
Published on 06/16/2025 at 14:50, 1 hour 15 minutes ago

1933 Industries Reports Profit in Third Quarter 2025 Financial Results
Published on 06/16/2025 at 14:30, 1 hour 35 minutes ago

Star Copper Announces Closing of C$1.25M Second Tranche of Flow Through Private Placement
Published on 06/16/2025 at 14:30, 1 hour 35 minutes ago

DTW 2025: Amdocs Unveils MVNO&GO: A SaaS Platform to Accelerate Digital Connectivity for MVNOs

View all ACCESSWIRE

EQS Group

Published on 06/16/2025 at 15:32, 32 minutes ago

Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Published on 06/16/2025 at 15:17, 47 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 06/16/2025 at 15:16, 48 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 06/16/2025 at 15:16, 49 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
Published on 06/16/2025 at 15:15, 49 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc

Les Echos

Published on 06/16/2025 at 14:22, 1 hour 43 minutes ago

Déclaration des transactions sur actions propres réalisées du 09/06/2025 au 13/06/2025
Published on 06/16/2025 at 14:22, 1 hour 43 minutes ago

Statement of transactions in own shares from June 9, 2025 to June 13, 2025
Published on 06/16/2025 at 14:01, 2 hours 3 minutes ago

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 mai 2025
Published on 06/16/2025 at 14:01, 2 hours 3 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as at May 31, 2025
Published on 06/16/2025 at 07:30, 8 hours 35 minutes ago

FSDV : obtention du visa de l’AMF sur le prospectus

View all LES ECHOS COMFI WIRE